Terms: = Liver cancer AND MYH9, P35579, 4627, ENSG00000100345, DFNA17 AND Prognosis
3 results:
1. Identification of TLN1 as a prognostic biomarker to effect cell proliferation and differentiation in acute myeloid leukemia.
Cui D; Cui X; Xu X; Zhang W; Yu Y; Gao Y; Mei C; Zheng W
BMC Cancer; 2022 Sep; 22(1):1027. PubMed ID: 36175877
[TBL] [Abstract] [Full Text] [Related]
2. ENKUR expression induced by chemically synthesized cinobufotalin suppresses malignant activities of hepatocellular carcinoma by modulating β-catenin/c-Jun/myh9/USP7/c-Myc axis.
Hou R; Li Y; Luo X; Zhang W; Yang H; Zhang Y; Liu J; Liu S; Han S; Liu C; Huang Y; Liu Z; Li A; Fang W
Int J Biol Sci; 2022; 18(6):2553-2567. PubMed ID: 35414777
[TBL] [Abstract] [Full Text] [Related]
3. Silencing myh9 blocks HBx-induced GSK3β ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma.
Lin X; Li AM; Li YH; Luo RC; Zou YJ; Liu YY; Liu C; Xie YY; Zuo S; Liu Z; Liu Z; Fang WY
Signal Transduct Target Ther; 2020 Feb; 5(1):13. PubMed ID: 32296025
[TBL] [Abstract] [Full Text] [Related]
